What is Multiple Myeloma?
by Kristen O'Connor
Multiple myeloma (also called myeloma or plasma cell myeloma) is a cancer of the plasma cells. Plasma cells are an important component of the immune system and are typically found in the bone marrow.
When functioning properly, plasma cells produce a variety of infection-fighting proteins called antibodies, or immunoglobulins. When a person has multiple myeloma, however, their plasma cells begin overproducing one type of abnormal antibody. This antibody is referred to as a monoclonal (M) protein. Monoclonal proteins cannot effectively fight infections and may also inhibit the production of normal blood cells due to overcrowding of the bone marrow.
As monoclonal proteins proliferate, they may form tumors called plasmacytomas. Plasmacytomas can be found wherever bone marrow is active, particularly the rib cage, the bones of the shoulder, the hip, and the spine. They may occur in multiple locations at one time, which is why the disease is called multiple myeloma.
Related Articles:
- Tools For Diagnosing Multiple Myeloma / Part 1: Diagnostic Evaluation
- Current Information On Response Criteria For Multiple Myeloma
- Anti-DKK1 Antibody As New Treatment For Myeloma Bone Disease
- Researchers Identify Novel Tumor Feeding Mechanism
- Macrophages May Contribute To Survival Of Multiple Myeloma Cells
Leave a comment